717133-32-9 Usage
Uses
Given the provided materials, there are no specific applications listed for (+/-)-4-[4-(diMethylaMino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxyMethyl)-benzonitrile, oxalate. However, based on its structure and potential as a pharmaceutical agent or research chemical, it can be inferred that (+/-)-4-[4-(diMethylaMino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxyMethyl)-benzonitrile, oxalate may be used in the following ways:
Used in Pharmaceutical Development:
(+/-)-4-[4-(diMethylaMino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxyMethyl)-benzonitrile, oxalate may be utilized as a pharmaceutical agent for the development of drugs targeting the central nervous system or other biological systems, due to its complex structure and the presence of functional groups commonly found in such drugs.
Used in Research and Development:
As a research chemical, (+/-)-4-[4-(diMethylaMino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxyMethyl)-benzonitrile, oxalate could be employed in scientific studies to explore its potential therapeutic properties, interactions with biological systems, and possible applications in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 717133-32-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,7,1,3 and 3 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 717133-32:
(8*7)+(7*1)+(6*7)+(5*1)+(4*3)+(3*3)+(2*3)+(1*2)=139
139 % 10 = 9
So 717133-32-9 is a valid CAS Registry Number.
717133-32-9Relevant academic research and scientific papers
process for the preparation of escitalopram
-
Page/Page column 4, (2009/04/24)
The present invention relates to an improved process for the preparation of Escitalopram of the Formula (I), which comprises, isolation of Diol compound as an oxalate salt, resolution of Diol compound and cyclization of resolved compound of Formula (VII). The present invention provides a process to obtain pure Diol compound by preparing its Oxalate salt, which is useful for resolution of enantiomers.
AN IMPROVED PROCESS FOR THE PREPARATION OF ESCITALOPRAM
-
Page/Page column 8, (2010/11/25)
The present invention relates to an improved process for the preparation of Escitalopram of the Formula (I), which comprises, isolation of Diol compound as an oxalate salt, resolution of Diol compound and cyclization of resolved compound of Formula (VII). The present invention provides a process to obtain pure Diol compound by preparing its Oxalate salt, which is useful for resolution of enantiomers .
